|
Re: Risk vs Reward moving forward!
|
14
|
Resverlogix Corp.
|
Dec 18, 2021 07:56AM
|
|
How to best promote apabetalone?
|
13
|
Resverlogix Corp.
|
Oct 30, 2017 01:33PM
|
|
Re: Constellation Pharma
|
13
|
Resverlogix Corp.
|
Jun 29, 2020 11:43AM
|
|
Dr. Kausik Ray will deliver the AHA Late Breaking Presentation on BETonMACE
|
12
|
Resverlogix Corp.
|
Nov 03, 2019 09:10AM
|
|
Re: FA
|
12
|
Resverlogix Corp.
|
May 15, 2018 02:47PM
|
|
Apabetalone’s Positive Effect on Hospitalized Patients Involving Heart Failure
|
12
|
Resverlogix Corp.
|
Jan 12, 2021 08:03AM
|
|
Re: BOM 2 Trial
|
12
|
Resverlogix Corp.
|
Jun 10, 2020 05:59PM
|
|
Re: Constellation Pharma
|
12
|
Resverlogix Corp.
|
Jun 29, 2020 10:17AM
|
|
Re: Apabetalone’s Beneficial Effects on COVID-19 Published in Prestigious Scientific Journal Cell
|
12
|
Resverlogix Corp.
|
Mar 17, 2021 08:10AM
|
|
Resverlogix NYAS Symposium notes
|
12
|
Resverlogix Corp.
|
Apr 29, 2016 12:50PM
|
|
A hunch about the below median LDL-C observation
|
12
|
Resverlogix Corp.
|
Nov 20, 2019 01:58PM
|
|
New RVX Publication in Atherosclerosis
|
12
|
Resverlogix Corp.
|
Jan 23, 2016 11:07PM
|
|
Re: "Targeted" Trial design
|
12
|
Resverlogix Corp.
|
Feb 04, 2021 04:46PM
|
|
The synergy of rosuvastatin (Crestor) with apabetalone
|
12
|
Resverlogix Corp.
|
Oct 03, 2019 08:23AM
|
|
ESC 2021 August 27-30
|
12
|
Resverlogix Corp.
|
Aug 02, 2021 05:41PM
|
|
Q4 2019 Events
|
12
|
Resverlogix Corp.
|
Oct 01, 2019 03:56PM
|
|
Re: Hopefully a late day pop?
|
11
|
Resverlogix Corp.
|
Apr 12, 2018 11:41PM
|
|
New Trial: Continuation Protocol for ZEN003694 in mCRPC Patients
|
11
|
Zenith Epigenetics
|
Oct 30, 2019 11:17AM
|
|
AHA Late Breaker!
|
11
|
Resverlogix Corp.
|
Sep 20, 2019 11:58AM
|
|
Re: Back to the FDA
|
11
|
Resverlogix Corp.
|
Oct 04, 2019 06:54AM
|
